Mylan to sell two drugs to get clearance for Meda buy
Drug giant Mylan has agreed to sell rights and assets related to products for treating muscle spasms and epilepsy to satisfy the government’s concerns that its $7.2 billion purchase of rival...To view the full article, register now.
Already a subscriber? Click here to view full article